Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

OXACILLIN SODIUM

OXACILLIN SODIUM

Standard Dose
EQ 1GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview OXACILLIN SODIUM is listed in Drugs@FDA under application 062737 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength POWDER;INTRAVENOUS - EQ 1GM BASE/VIAL Sponsor SANDOZ Submission history Latest submission status date: 2016-05-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview OXACILLIN SODIUM is listed in Drugs@FDA under application 062737 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OXACILLIN SODIUM Form and strength POWDER;INTRAVENOUS - EQ 1GM BASE/VIAL Sponsor SANDOZ Submission history Latest submission status date: 2016-05-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
OXACILLIN SODIUM (OXACILLIN SODIUM) | Drug Monograph | MedicHelpline